Published on Apr 3, 2011
Note:
this video has not been updated to reflect new membership features and
pricing. The information is still open access. Learn more about
professional membership features here: http://www.greenmedinfo.com/page/beco...
Sayer Ji, founder of GreenMedInfo.com, discusses his findings after reviewing
all 5000 study abstracts on Turmeric (and its primary polyphenol Curcumin) on the US National Library Medicine's database (pubmed.gov). GreenMedInfo.com now houses 1500 carefully indexed studies on this plant, indexed across 600+ diseases and 160+ pharmacological actions. The research can be found here http://www.greenmedinfo.com/substance...
600 Reasons Turmeric May Be The World’s Most Important Herb
GreenMedInfo.com
There is a medicinal spice so timelessly interwoven with the origins of human culture and metabolism, so thoroughly supported by modern scientific inquiry, as to be unparalleled in its proven value to human health and well-being.
Indeed, turmeric turns the entire drug-based medical model on its head. Instead of causing far more side effects than therapeutic ones, as is the case for most patented pharmaceutical medications, turmeric possesses hundreds of potential side benefits, having been empirically demonstrated to positively modulate over 160 different physiological pathways in the mammalian body.
While no food or herb is right for everyone, and everything has the potential for unintended, adverse side effects, turmeric is truly unique in its exceptionally high margin of safety vis-à-vis the drugs it has been compared with, e.g. hydrocortisone, ibuprofen, chemotherapy agents. Furthermore, nothing within the modern-day pharmaceutical armamentarium comes even remotely close to turmeric’s 6,000 year track record of safe use in Ayurvedic medicine.[1]
Despite its vast potential for alleviating human suffering, turmeric will likely never receive the FDA stamp of approval, due to its lack of exclusivity, patentability and therefore profitability. Truth be told, the FDA’s “gold standard” for proving the value of a prospective medicinal substance betrays the age old aphorism: “he who owns the gold makes the rules,” and unless an investor is willing to risk losing the 800+ million dollars that must be spent upfront, the FDA-required multi-phased double-blind, randomized clinical trials will not occur. For additional details on this rather seedy arrangement read our article on the topic:
Why The Law Forbids The Medicinal Use of Natural Substances.
Read More Here
*****************************************************************
Related articles
No comments:
Post a Comment
Hello and thank you for visiting my blog. Please share your thoughts and leave a comment :)